Cite
Upregulation of the long noncoding RNA FOXD2-AS1promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer
MLA
Xu, Tong-peng, et al. “Upregulation of the Long Noncoding RNA FOXD2-AS1promotes Carcinogenesis by Epigenetically Silencing EphB3 through EZH2 and LSD1, and Predicts Poor Prognosis in Gastric Cancer.” Oncogene, vol. 37, no. 36, Sept. 2018, pp. 5020–36. EBSCOhost, https://doi.org/10.1038/s41388-018-0308-y.
APA
Xu, T., Wang, W., Ma, P., Shuai, Y., Zhao, K., Wang, Y., Li, W., Xia, R., Chen, W., Zhang, E., & Shu, Y. (2018). Upregulation of the long noncoding RNA FOXD2-AS1promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Oncogene, 37(36), 5020–5036. https://doi.org/10.1038/s41388-018-0308-y
Chicago
Xu, Tong-peng, Wen-yu Wang, Pei Ma, You Shuai, Kun Zhao, Yan-fen Wang, Wei Li, et al. 2018. “Upregulation of the Long Noncoding RNA FOXD2-AS1promotes Carcinogenesis by Epigenetically Silencing EphB3 through EZH2 and LSD1, and Predicts Poor Prognosis in Gastric Cancer.” Oncogene 37 (36): 5020–36. doi:10.1038/s41388-018-0308-y.